- Home
- CTLT vs KEP Comparison
CTLT vs KEP Comparison
Compare CTLT & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLT
- KEP
- Stock Information
- Founded
- CTLT 2007
- KEP 1961
- Country
- CTLT United States
- KEP South Korea
- Employees
- CTLT N/A
- KEP N/A
- Industry
- CTLT Biotechnology: Pharmaceutical Preparations
- KEP Electric Utilities: Central
- Sector
- CTLT Health Care
- KEP Utilities
- Exchange
- CTLT Nasdaq
- KEP Nasdaq
- Market Cap
- CTLT 11.0B
- KEP 9.4B
- IPO Year
- CTLT 2014
- KEP N/A
- Fundamental
- Price
- CTLT $59.12
- KEP $8.18
- Analyst Decision
- CTLT Hold
- KEP
- Analyst Count
- CTLT 7
- KEP 0
- Target Price
- CTLT $59.83
- KEP N/A
- AVG Volume (30 Days)
- CTLT 1.9M
- KEP 87.7K
- Earning Date
- CTLT 11-05-2024
- KEP 12-01-2024
- Dividend Yield
- CTLT N/A
- KEP N/A
- EPS Growth
- CTLT N/A
- KEP N/A
- EPS
- CTLT N/A
- KEP 4.40
- Revenue
- CTLT $4,422,000,000.00
- KEP $70,353,869,926.00
- Revenue This Year
- CTLT $8.58
- KEP $5.44
- Revenue Next Year
- CTLT $7.95
- KEP $3.10
- P/E Ratio
- CTLT N/A
- KEP $3.68
- Revenue Growth
- CTLT 4.71
- KEP 8.48
- 52 Week Low
- CTLT $36.74
- KEP $6.69
- 52 Week High
- CTLT $61.20
- KEP $9.55
- Technical
- Relative Strength Index (RSI)
- CTLT 45.31
- KEP 54.90
- Support Level
- CTLT $59.34
- KEP $7.58
- Resistance Level
- CTLT $60.21
- KEP $8.30
- Average True Range (ATR)
- CTLT 0.52
- KEP 0.10
- MACD
- CTLT 0.02
- KEP -0.02
- Stochastic Oscillator
- CTLT 43.08
- KEP 74.07
About CTLT Catalent Inc.
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.